Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - ALNYLAM PHARMACEUTICALS, INC.Financial_Report.xls
10-Q - FORM 10-Q - ALNYLAM PHARMACEUTICALS, INC.d599634d10q.htm
EX-31.2 - EX-31.2 - ALNYLAM PHARMACEUTICALS, INC.d599634dex312.htm
EX-32.1 - EX-32.1 - ALNYLAM PHARMACEUTICALS, INC.d599634dex321.htm
EX-32.2 - EX-32.2 - ALNYLAM PHARMACEUTICALS, INC.d599634dex322.htm
EX-31.1 - EX-31.1 - ALNYLAM PHARMACEUTICALS, INC.d599634dex311.htm

Exhibit 12

STATEMENT REGARDING COMPUTATION OF CONSOLIDATED RATIOS OF EARNINGS/DEFICIENCIES TO FIXED CHARGES

(dollars in thousands)

 

                Fiscal Year Ended December 31,  
    Nine
Months Ended
September 30,
2013
    Three
Months Ended
September 30,
2013
    2012     2011     2010     2009     2008  

Earnings (loss):

             

Pre-tax loss from continuing operations before adjustment for loss from equity investee

  $ (62,584   $ (31,956   $ (112,064   $ (54,144   $ (35,362   $ (42,098   $ (16,240

add: Fixed charges (see below)

    543        154        1,188        1,207        1,207        712        1,115   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Pre-tax loss from continuing operations before adjustment for income/loss from equity investees plus fixed charges

  $ (62,041   $ (31,802   $ (110,876   $ (52,937   $ (34,155   $ (41,386   $ (15,125

Fixed charges:

             

Interest expense on indebtedness

  $ —        $ —        $ —        $ —        $ —        $ —        $ 872   

Interest expense on portion of rent expense representative of interest

    543        154        1,188        1,207        1,207        712        243   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total fixed charges

    543      $ 154      $ 1,188      $ 1,207      $ 1,207      $ 712      $ 1,115   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratio of earnings to fixed charges

    —          —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Deficiency of earnings available to cover fixed charges

    (62,584   $ (31,956   $ (112,064   $ (54,144   $ (35,362   $ (42,098   $ (16,240